FM
Frazier Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,747,622
| Closed | -$33.4M | – | 14 |
|
|
2021
Q4 | $33.4M | Sell |
1,747,622
-926,677
| -35% | -$17.7M | 2.57% | 13 |
|
|
2021
Q3 | $65.9M | Buy |
2,674,299
+536,300
| +25% | +$13.2M | 5.28% | 4 |
|
|
2021
Q2 | $55.6M | Buy |
2,137,999
+825,000
| +63% | +$21.5M | 5.13% | 6 |
|
|
2021
Q1 | $41.6M | Hold |
1,312,999
| – | – | 3.33% | 8 |
|
|
2020
Q4 | $60.9M | Hold |
1,312,999
| – | – | 4.69% | 7 |
|
|
2020
Q3 | $43.2M | Hold |
1,312,999
| – | – | 3.88% | 6 |
|
|
2020
Q2 | $36M | Sell |
1,312,999
-437,666
| -25% | -$12M | 3.16% | 9 |
|
|
2020
Q1 | $52.4M | Hold |
1,750,665
| – | – | 5.94% | 4 |
|
|
2019
Q4 | $48.5M | Hold |
1,750,665
| – | – | 8.13% | 4 |
|
|
2019
Q3 | $31.9M | Sell |
1,750,665
-437,666
| -20% | -$7.97M | 9.96% | 3 |
|
|
2019
Q2 | $53.7M | Hold |
2,188,331
| – | – | 13.75% | 2 |
|
|
2019
Q1 | $20.8M | Hold |
2,188,331
| – | – | 5.01% | 7 |
|
|
2018
Q4 | $19.4M | Hold |
2,188,331
| – | – | 5% | 5 |
|
|
2018
Q3 | $24.6M | Hold |
2,188,331
| – | – | 4.51% | 6 |
|
|
2018
Q2 | $28M | Hold |
2,188,331
| – | – | 5.8% | 6 |
|
|
2018
Q1 | $37M | Hold |
2,188,331
| – | – | 6.14% | 4 |
|
|
2017
Q4 | $17.5M | Hold |
2,188,331
| – | – | 2.84% | 8 |
|
|
2017
Q3 | $17M | Hold |
2,188,331
| – | – | 6.05% | 6 |
|
|
2017
Q2 | $15.2M | Hold |
2,188,331
| – | – | 7.8% | 5 |
|
|
2017
Q1 | $16.3M | Hold |
2,188,331
| – | – | 8.71% | 4 |
|
|
2016
Q4 | $15.2M | Buy |
2,188,331
+101,050
| +5% | +$702K | 19.14% | 2 |
|
|
2016
Q3 | $17.2M | Buy |
2,087,281
+1,312,561
| +169% | +$10.8M | 8.43% | 4 |
|
|
2016
Q2 | $6.28M | Buy |
+774,720
| New | +$6.28M | 5.01% | 6 |
|